IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 03:10PM GMT
Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Thanks for joining us. My name is Tejas Savant, and I'm the life science tools and diagnostics analyst at Morgan Stanley. It's my pleasure to host IQVIA this morning. And representing the company, we have Ron Bruehlman, CFO. So thanks, Ron, for doing this.

Ronald E. Bruehlman - IQVIA Holdings Inc. - Executive VP & CFO

You're very welcome.

Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

Before we get started, a quick disclaimer statement, please go to morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.

Questions and Answers:

Tejas Rajeev Savant - Morgan Stanley, Research Division - Equity Analyst

So perhaps, Ron, just to kick things off, can you just outline what you view as IQVIA's key accomplishments this year? And what are you most excited about as you look to 2023?

Ronald E. Bruehlman
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot